Phase II study of weekly docetaxel (Taxotere; txt) and trastuzumab (Herceptin; H) for patients with HER-2 overexpressing (HER2+) metastatic breast cancer (MBC)
Year: 2001
Type: article
Source: European Journal of Cancer
Authors: F.J. Esteva, V. Valero, D. Booser, L.T. Guerra, J.L. Murray, L. Pusztai, M. Cristofanilli, N. Sneige, T.L. Smith, G.N. Hortobagyi
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2070038138